Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia
Condition(s):Endometrial HyperplasiaLast Updated:July 5, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Endometrial HyperplasiaLast Updated:July 5, 2023Withdrawn
Condition(s):ContraceptionLast Updated:August 7, 2019Completed
Condition(s):Menopausal Syndrome; Cardiovascular Disease; Osteoporosis; Breast CancerLast Updated:October 2, 2012Unknown status
Condition(s):ContraceptionLast Updated:June 17, 2019Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:November 9, 2022Active, not recruiting
Condition(s):Menstrual Cycle; Hormonal ContraceptionLast Updated:February 28, 2024Recruiting
Condition(s):ContraceptionLast Updated:February 22, 2024Recruiting
Condition(s):Asherman SyndromeLast Updated:September 8, 2021Unknown status
Condition(s):Intrauterine AdhesionLast Updated:September 17, 2021Recruiting
Condition(s):Oral ContraceptiveLast Updated:September 10, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.